Dysphagia therapy in Multiple Sclerosis
Phase 3
- Conditions
- Dysphagia.Difficulty in swallowing
- Registration Number
- IRCT2016022426721N2
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Inclusion Criteria
1- Multiple Sclerosis patient; 2- age ranges 20-60; 3- Not having history of relapses and not receiving steroid drugs in the last month; 4- Not having history of stroke, Parkinson's disease, cervical spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis and myasthenia gravis; 5- Not having history of cognitive disorders such as Dementia; 4- dysphagia and aspiration diagnosed by MASA test; 6-Not having history of receiving any dysphagia therapy;
Exclusion criteria: 1- Having Severe reflux; 2- Having Dysphagia due to drug toxicity; 3- Pregnancy; 4- The patient's unwillingness to continue treatment
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MASA Score. Timepoint: Beginning the first week, End of the third week, End of the sixth week, End of the twelfth week. Method of measurement: standard questionaire.
- Secondary Outcome Measures
Name Time Method Aspiration-Penetration Scale Score. Timepoint: Beginning the first week, End of the third week, End of the sixth week, End of the twelfth week. Method of measurement: Fiberoptic Endoscopic Evaluation of Swallowing.